Causes and severity factors
The sole and primary cause of this condition is significant acute blood loss. The pathological process is triggered when the body rapidly loses fluid and red blood cells.
The severity of the patient's condition is determined by two main criteria:
- Volume of blood loss. The more blood that leaves the vascular bed, the worse the prognosis.
- Rate of blood loss. Acute and rapid bleeding leaves the body less time to adapt.
The critical level is considered to be a situation where the patient loses 25–30% of their circulating blood volume (CBV). Such massive and rapid depletion of reserves inevitably leads to severe shock requiring emergency medical intervention.
Classification and clinical presentation
Depending on the preservation of the body's compensatory mechanisms, three sequential stages of the syndrome are distinguished. Each of them is characterized by specific changes in hemodynamics, the central nervous system (CNS), skin, and renal function.
- Compensated shock
At this stage, the body is still attempting to maintain life support on its own.
- Skin: marked pallor is noted, the patient is covered in cold sweat.
- Hemodynamics: the pulse becomes thready and rapid. Blood pressure (BP) remains within normal limits or is only slightly reduced.
- Renal function: urine output is noticeably decreased.
- Decompensated reversible shock
Reserves are depleted, but with timely assistance, the process can be reversed.
- Skin: pallor is replaced by cyanosis (bluish discoloration) of the skin and visible mucous membranes.
- CNS: the patient is conscious, but obvious lethargy of reactions is observed.
- Hemodynamics: the pulse remains thready and rapid, a drop in blood pressure and a decrease in central venous pressure (CVP) are recorded. Additionally, ECG signs of myocardial ischemia are detected.
- Renal function: oliguria develops (a sharp decrease in urine output).
- Irreversible shock
The terminal phase, during which fatal changes occur.
- Skin: acquires a characteristic "mottled" appearance.
- CNS: consciousness is completely absent.
- Hemodynamics: blood pressure drops so low that it cannot be measured at all.
- Renal function: anuria ensues—the complete cessation of urine output.
Condition assessment and treatment principles
To accurately assess the severity of the victim's condition, the physician must rely on several objective parameters. It is extremely important to determine CBV (circulating blood volume) and calculate the absolute volume of blood loss. Another crucial diagnostic criterion is the Allgöwer index — this indicator is consistently high in hemorrhagic shock.
Treatment tactics are built upon three fundamental steps that are performed immediately:
- Stopping the bleeding. This is the primary objective; without eliminating the source of blood loss, any other measures are ineffective.
- Infusion therapy. Aimed at the prompt replenishment and restoration of normal circulating blood volume.
- Use of vasodilators. Used to correct vascular tone and improve microcirculation after baseline volumes have been restored.
Briefly: answers to topical questions
What is the formula for calculating the Allgöwer index?
The Allgöwer index is calculated as the ratio of heart rate to systolic blood pressure.
Calculation formula: Index = Heart rate (bpm) / SBP (mmHg).
Interpretation of values:
- 0.5 — normal value;
- 1.0 — indicates the transition from an early stage to pronounced shock (blood loss of 20–30% of CBV);
- 1.5 — indicates advanced shock.
The higher the resulting index, the more severe the shock and the worse the prognosis for the patient.
Which groups of drugs are used for infusion therapy in hemorrhagic shock?
Blood substitutes and blood products are used for infusion therapy in hemorrhagic shock.
Main drug groups:
- Colloids — retained well within the vascular bed (albumin, protein, gelatin, medium- and low-molecular-weight dextrans).
- Crystalloids — replenish volume but leave the vascular bed quickly (Ringer's solution, isotonic sodium chloride solution, 5% dextrose solution).
- Blood products — red blood cell mass is administered after volume expanders to improve capillary blood flow and reduce pooling.
Class and exam questions
What is the main etiological factor of hemorrhagic shock?
The main cause is always significant acute blood loss. Chronic bleeding typically does not lead to this type of shock due to the body's adaptation.
What level of blood loss is considered critical for the development of severe shock?
The critical threshold is considered to be the loss of 25% to 30% of circulating blood volume (CBV).
How does blood pressure change at different stages?
In the compensated stage, blood pressure is normal or slightly reduced; in the decompensated reversible stage, it is noticeably reduced; and in the irreversible stage, it is not detectable at all.
What changes in diuresis are characteristic of this condition?
As severity progresses, urine output drops: in the compensated stage, diuresis is simply decreased; in the decompensated stage, oliguria develops; in the irreversible stage, anuria occurs (complete cessation of urine output).
What else to study on this topic
- Compensation mechanisms during reduced CBV
- Calculation and clinical significance of the Allgöwer index
- Methods for reliable cessation of acute bleeding
- Drugs for infusion therapy and CBV replenishment
- Principles and timing of vasodilator administration
Master the entire topic in the "General Surgery" course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Hemorrhagic shock" and another 3,335 pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 70 video lessons on the subject
Other topics from the section "CHAPTER 4. EMERGENCY CARE IN CRITICAL CONDITIONS"
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.